Karen horgan ✉
Co-founder & CEO
Karen co-founded VAL Health after identifying an opportunity to apply behavioral economics to improve healthcare. A proven expert in developing high impact incentive programs, Karen is commonly found presenting at leading industry conference and private speaking events. Prior to joining VAL Health, Karen was Chief Marketing Officer at Keystone Strategy, a consulting firm affiliated with experts from Harvard, University of Pennsylvania and MIT, where she led global client engagements to develop R&D and innovation solutions for Fortune 500 companies including PepsiCo, Microsoft and Johnson & Johnson. Karen also previously led marketing and product management teams for early-stage technology companies, and was a consultant with Bain and Company in Boston and Hong Kong.
Karen holds an MBA from the Harvard Business School, a BA from the University of Pennsylvania and a BS from the Wharton School of the University of Pennsylvania.
EMILY BOYM ✉
Senior Engagement Manager
Passionate about healthcare and health policy, Emily is a knowledgeable strategy consultant with experience leading projects across diverse health industry stakeholders. From project kickoff through completion, she works with clients to hone in on the true challenges and develop actionable solutions grounded in proven science. Emily regularly manages teams to develop solutions to drive initial and ongoing engagement, design custom incentives strategies, and improve specific and broad quality measures. Prior to joining VAL Health, she was a Manager with PwC's Strategy& consulting group, focused on healthcare payers and industry new entrants and innovators.
Emily holds an MPH from Columbia University's Mailman School of Public Health and a BS from Emory University.
Georgia Buck ✉
Vice President, Business Development
Georgia Buck is a seasoned health care executive with deep experience in health management, wellness, and health care analytics. She develops innovative solutions to support clients in meeting their objectives. Throughout her career, Georgia has developed new markets and contributed to rapid company growth through sales, partnership development, and strategic account management. Prior to joining VAL Health, Georgia served as Vice President, Business Development at Telcare, a mhealth diabetes company. Earlier in her career, she held senior positions at Health Dialog, WebMD, Health Share Technology, HealthHelp, NorthEast Imaging, and Blue Cross Blue Shield of Massachusetts.
Georgia holds a BS in Health Care Management from Northeastern University.
Arnab Chaudhurri ✉
Director of engineering
Arnab Chaudhuri is an accomplished software engineer and architect who has led engineering teams in developing a wide range of e-commerce and data-driven web and mobile applications. At VAL Health, Arnab is responsible for all technical components of the VAL Health Rewards platform. Prior to joining VAL Health, Arnab was a lead developer and manager of multiple engineering teams at TravelClick, where he led the development of web, mobile, and call center reservation systems as well as the implementation of reporting and analytics platforms to increase revenue and customer engagement for hotels. Arnab has previously produced diverse technology solutions for companies such as WeightWatchers, Kodak, IBM, and World Wrestling Entertainment.
Arnab holds a JD from Cornell University Law School, and a BS in Computer Science from Duke University.
James Patton ✉
Co-Founder & Chairman
Jim is a board-certified internist and has over twenty-five years of experience in building health care businesses as an investor, owner, and manager. He is a founder and co-owner of Millennium Oncology Management, a consulting and physician management company. He is a founder and board member of Advaxis, a publicly-traded immuno-oncology company. Previously, Jim was Medical Director and Vice-President of HealthExpress, a start-up focused on individual and employer health and wellness programs, and was an officer of Universal Health Services, a publicly-traded hospital management company. Jim has experience as a venture capitalist where he led investments in health informatics, biotechnology, and service providers. Jim served two years on active duty in the United States Navy as a general medical officer. He and Dr. Asch collaborated at the University of Pennsylvania on several projects in the field of medical decision making.
Jim holds a MD from the Medical College of Pennsylvania, an MBA from The Wharton School and a BS from the University of Michigan.
Scientific Advisory Board
Dr. David Asch is the John Morgan Professor of Medicine and Professor of Medical Ethics and Health Policy at the Perelman School of Medicine at the University of Pennsylvania and Professor of Health Care Management and of Operations, Information and Decisions at the Wharton School. He is Executive Director of the Penn Medicine Center for Innovation. He created and from 2001 to 2012 directed the Center for Health Equity Research and Promotion—the Department of Veterans Affairs’ national center to support vulnerable populations and reduce racial disparities. From 1998 to 2012 he was the Executive Director of the Leonard Davis Institute of Health Economics at the University of Pennsylvania, the largest university-based health policy research organization in the world.
Awards and Honors
John M. Eisenberg National Award for Career Achievement in Research from the Society of General Internal Medicine (2010)
VA Under Secretary’s Award for Outstanding Achievement in Health Services Research (2008)
Alice S. Hersh New Investigator Award from AcademyHealth (1997)
Elected member of the Association of American Physicians and the National Academy of Medicine (formerly the Institute of Medicine) of the National Academy of Sciences
MBA from The Wharton School of the University of Pennsylvania
MD from Cornell University
AB from Harvard Univeristy
Dr. Kevin Volpp is the founding Director of the Leonard Davis Institute Center for Health Incentives and Behavioral Economics, which is the home of one of two NIH-funded Centers on Behavioral Economics and Health, and the Co-Director of the University of Pennsylvania Medicine Center for Health Care Innovation. He is also a Professor of Medicine at the Perelman School of Medicine and of Health Care Management at the Wharton School of the University of Pennsylvania. Dr. Volpp's research program focuses on the impact of financial and organizational incentives on health outcomes.
Awards and Honors
Article of the Year Award, Academy Health Annual Meeting, Boston, MA (2016)
Association for Clinical and Translational Science (ACTS) Distinguished Investigator Award for Translation from Clinical Use into Public Benefit and Policy (2015)
Matilda White Riley Award For Contributions to Social and Behavioral Science, 20th anniversary of the Office of Social and Behavioral Sciences Research, NIH (2015)
Elected member of the American Society of Clinical Investigation (ASCI), the Association of American Physicians (AAP), and the Institute of Medicine of the National Academy of Sciences
PHD from The Wharton School of the University of Pennsylvania
MD from the University of Pennsylvania
AB from Harvard University
Dr. George Loewenstein is the Herbert A. Simon Professor of Economics and Psychology at Carnegie Mellon University, a founder of the fields of behavioral economics and neuroeconomics, and one of the leading thinkers examining the interface between economics and psychology, with more than 100 publications in peer-reviewed journals on topics in behavioral economics. He is the former president of the Society for Judgment and Decision Making, a member of the Russell Sage Foundation Behavioral Economics Roundtable, and served on the board of the Society for Neuroeconomics. With a book on Behavioral Economics and Human Motivation, (Oxford University Press), he is a specialist on the topic of human motivation and on the motivational effects of economic and non-economic incentives. He has also done extensive research on the topic of intertemporal choice (choices between immediate and delayed costs and benefits), on the regulation of visceral urges, such as hunger, pain and drug craving, and on decision making under risk. In recent years, he is one of a small group of behavioral economics who have been attempting to use the tools of their field not only to identify limitations in human decision making, but to improve it. He has worked closely with Dr. Volpp on a number of studies testing the effectiveness of patient incentives in a range of clinical areas including obesity, medication adherence, and mental acuity for older adults.
Awards and Honors
Honorary Doctorate of Science, University of Warwick (2014)
Best Paper Award (with Daylian Cain and Sunita Sah), Society for Business Ethics annual meeting (2010)
Hillel Einhorn New Investigator award, Judgment/Decision Making Society (1988)
PhD in Economics from Yale University
BA from Brandeis University
Andrea B. Troxel, ScD is Professor of Population Health and Director of the Division of Biostatistics in the Department of Population Health at New York University School of Medicine. She is an elected Fellow of the American Statistical Association. Dr. Troxel is an expert on statistical methodology in the areas of missing data, longitudinal studies, and clinical trials. She has developed new approaches for handling non-ignorable missing data and informative observation processes in longitudinal studies, as well as innovations in the design and analysis of pragmatic trials. Dr. Troxel’s collaborative activities focus on oncology and behavioral economics; she has a wide range of experience with all phases of clinical research, including large-scale epidemiologic studies, early-phase clinical trials, and definitive randomized controlled trials. She has published more than 200 articles in peer-reviewed journals on these and other topics.
ScD from Harvard University
BS from Yale University
Dr. Sara Bleich is a Professor of Public Health Policy at the Harvard T.H. Chan School of Public Health in the Department of Health Policy and Management. She is also the Carol K. Pforzheimer Professor at the Radcliffe Institute for Advanced Study. Dr. Bleich’s scholarship lies at the nexus of health policy and health services research. Her research provides evidence to support policy alternatives for obesity prevention and control, particularly among populations at higher risk for obesity. A signature theme throughout her work is an interest in asking simple, meaningful questions about the complex problem of obesity which can fill important gaps in the literature. Her research has been published in journals such as the New England Journal of Medicine, Health Affairs, and American Journal of Public Health and has been featured in outlets such as the New York Times, the Wall Street Journal, and National Public Radio.
Awards and Honors
White House Fellow as a Senior Policy Advisor to the U.S. Department of Agriculture and the First Lady’s Let’s Move initiative (2015-2016)
Excellence in Public Interest Communication, Frank Conference (2015)
Best Research Manuscript, Obesity (2012)
Most Outstanding Abstract, International Conference on Obesity (2006)
PhD from Harvard University
BA from Columbia University